Skip to main content
Logo

What we fund

Global Health EDCTP3 supports all the elements required to develop and evaluate medical interventions against the key infectious diseases affecting sub-Saharan Africa.

Tackling priority diseases

We concentrate on infectious diseases with the highest impact in sub-Saharan Africa:

  • HIV
  • Tuberculosis (TB)
  • Malaria
  • Neglected infectious diseases
  • Diarrhoeal diseases
  • Lower respiratory tract infections
  • Emerging and re-emerging infectious diseases
  • Co-infections, comorbidities and their interaction with non-communicable diseases (NCDs)

We also address cross-cutting global health challenges:

  • Antimicrobial resistance (AMR)
  • Epidemic preparedness
  • Health effects of climate change (including climate-driven shifts in disease patterns)
  • Digital health solutions

Accelerating medical innovation

We fund clinical research to evaluate:

  • drugs,
  • vaccines,
  • therapies,
  • diagnostics,
  • other medical tools.

Our support covers all stages of clinical development, with a particular emphasis on late-stage trials (phases III and IV) and real-world implementation research to support uptake in health systems, including safety monitoring, field trials and effectiveness studies.

Strengthening health research ecosystems

We strengthen the foundations for high-quality, ethical clinical research in sub-Saharan Africa by:

  • Supporting the development of infrastructure and research systems.
  • Enhancing regulatory and legal frameworks.
  • Improving ethics review processes.
  • Building institutional capacity for sustainable research.

Investing in future leaders

We foster a new generation of scientific leaders in Africa by:

  • Supporting researchers at all career stages, from Master’s and PhD students to postdoctoral fellows.
  • Providing tailored training opportunities.
  • Enabling networking and collaboration, including through the EDCTP Alumni Network.

How our funding works

  • Regular calls for proposals are launched every year, guided by the Strategic Research & Innovation Agenda (SRIA).
  • Applicants submit proposals to address priority topics in infectious disease research and capacity building.
  • Independent experts evaluate the proposals by assessing excellence, impact, and quality of implementation.
  • Selected projects receive funding from the European Union and participating states, often complemented by financial backing from contributing partners.

Find out more about how to apply for funding   Meet our funding partners